Home
Medigen Biotechnology

Medigen Biotechnology Market Share Analysis for November 2025

Health > Biotechnology and Pharmaceuticals

Domainmedigen.com.tw

Year Founded1999

Employees51 - 200

Annual Revenue$5M - $10M

Medigen Biotechnology

Medigen Biotechnology (including company regionals)

medigen.com.tw

See more website traffic and engagement information

Medigen Biotechnology Revenue up to November 2025 is 5M - 10M

revenue generated by Medigen Biotechnology top domains

Medigen Biotechnology top domains revenue over 3 years

Revenue for Medigen Biotechnology top domains

medigen.com.tw5M - 10M

See more with Sales Intelligence

Total visits to Medigen Biotechnology's top domains

Understand Medigen Biotechnology market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

medigen.com.tw954

See more with Sales Intelligence

Avg. visit duration in Medigen Biotechnology's top domains

Analyze Medigen Biotechnology engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

medigen.com.tw00:01:08

See more with Sales Intelligence

Avg. pageviews on Medigen Biotechnology's top domains

See how Medigen Biotechnology keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

medigen.com.tw2.08

See more with Sales Intelligence

Medigen Biotechnology top competitors by domain

Top similar sites in November 2025, ranked by their affinity

oep.com.twCompany NameOrient EuroPharma Co., Ltd.Employees501 - 1000HQTaiwan, TaipeiAnnual revenue--Total visits14.9KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Medigen Biotechnology

These are the website technologies, by industry, used by Medigen Biotechnology top domains

Audio Video Media (2)

YouTube

Content Management System (2)

WordPress

Mobile (2)

Meta Viewport

Widget (2)

Twemoji

More Technologies

3

See all

News & Signals from Medigen Biotechnology

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsMedigen Biotechnology Corp. is developing COVID-19 vaccine patch.Taiwanese drugmaker Medigen is partering with a US biotechnology company to develop a COVID-19 vaccine patch, for which human clinical trials could begin as early as next year, the firm announced on Monday.

NewsMedigen Biotechnology Corp. is developing COVID vaccine.Dynavax and Medigen announced a collaboration in July 2020 to develop a COVID vaccine using Dynavax's CpG 1018 adjuvant.

NewsCellMax Technologies AB. partners with Medigen Biotechnology Corp..CellMax, a leading cancer diagnostics company, based in California, has reportedly announced that it has partnered with Medigen Biotech, in a bid to provide the latter with the CMxTM (its circulating tumor cell platform).